Cargando…

GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response

Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianli, Hu, Yanyan, Kuang, Zhongshu, Chen, Yao, Xing, Lingyu, Wei, Wei, Xue, Mingming, Mu, Sucheng, Tong, Chaoyang, Yang, Yilin, Song, Zhenju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841418/
https://www.ncbi.nlm.nih.gov/pubmed/35173706
http://dx.doi.org/10.3389/fimmu.2021.789141
_version_ 1784650831474196480
author Wang, Jianli
Hu, Yanyan
Kuang, Zhongshu
Chen, Yao
Xing, Lingyu
Wei, Wei
Xue, Mingming
Mu, Sucheng
Tong, Chaoyang
Yang, Yilin
Song, Zhenju
author_facet Wang, Jianli
Hu, Yanyan
Kuang, Zhongshu
Chen, Yao
Xing, Lingyu
Wei, Wei
Xue, Mingming
Mu, Sucheng
Tong, Chaoyang
Yang, Yilin
Song, Zhenju
author_sort Wang, Jianli
collection PubMed
description Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response.
format Online
Article
Text
id pubmed-8841418
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88414182022-02-15 GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response Wang, Jianli Hu, Yanyan Kuang, Zhongshu Chen, Yao Xing, Lingyu Wei, Wei Xue, Mingming Mu, Sucheng Tong, Chaoyang Yang, Yilin Song, Zhenju Front Immunol Immunology Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response. Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8841418/ /pubmed/35173706 http://dx.doi.org/10.3389/fimmu.2021.789141 Text en Copyright © 2022 Wang, Hu, Kuang, Chen, Xing, Wei, Xue, Mu, Tong, Yang and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Jianli
Hu, Yanyan
Kuang, Zhongshu
Chen, Yao
Xing, Lingyu
Wei, Wei
Xue, Mingming
Mu, Sucheng
Tong, Chaoyang
Yang, Yilin
Song, Zhenju
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_full GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_fullStr GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_full_unstemmed GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_short GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_sort gpr174 mrna acts as a novel prognostic biomarker for patients with sepsis via regulating the inflammatory response
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841418/
https://www.ncbi.nlm.nih.gov/pubmed/35173706
http://dx.doi.org/10.3389/fimmu.2021.789141
work_keys_str_mv AT wangjianli gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT huyanyan gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT kuangzhongshu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT chenyao gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT xinglingyu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT weiwei gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT xuemingming gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT musucheng gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT tongchaoyang gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT yangyilin gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT songzhenju gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse